Your browser doesn't support javascript.
loading
Comparison of real-world treatment outcomes of systemic immunomodulating therapy in atopic dermatitis patients with dark and light skin types.
Bosma, Angela L; Ouwerkerk, Wouter; Heidema, Madeline J; Prieto-Merino, David; Ardern-Jones, Michael R; Beattie, Paula; Brown, Sara J; Ingram, John R; Irvine, Alan D; Ogg, Graham; Patel, Prakash; Reynolds, Nick J; Hearn, R M Ross; Wan, Mandy; Warren, Richard B; Woolf, Richard T; Hyseni, Ariënna M; Gerbens, Louise A A; Spuls, Phyllis I; Flohr, Carsten; Middelkamp-Hup, Maritza A.
Affiliation
  • Bosma AL; Department of Dermatology, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.
  • Ouwerkerk W; Department of Dermatology, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.
  • Heidema MJ; NHRIS, National Heart Centre Singapore, Singapore.
  • Prieto-Merino D; Department of Dermatology, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.
  • Ardern-Jones MR; Faculty of Medicine, Universidad de Alcalá, Madrid, Spain.
  • Beattie P; Unit for Population-Based Dermatology Research, St John's Institute of Dermatology, Guy's & St Thomas' NHS Foundation Trust and King's College London, London, UK.
  • Brown SJ; Clinical Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Ingram JR; Department of Dermatology, University Hospitals NHS Foundation Trust, Southampton, UK.
  • Irvine AD; Department of Dermatology, Royal Hospital for Children NHS Trust, Glasgow, UK.
  • Ogg G; Centre for Genomic and Experimental Medicine, University of Edinburgh, Edinburgh, UK.
  • Patel P; Department of Dermatology, Division of Infection & Immunity, Cardiff University, Cardiff, UK.
  • Reynolds NJ; Department of Clinical Medicine, Trinity College Dublin, Dublin, Ireland.
  • Hearn RMR; MRC Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
  • Wan M; Unit for Population-Based Dermatology Research, St John's Institute of Dermatology, Guy's & St Thomas' NHS Foundation Trust and King's College London, London, UK.
  • Warren RB; Department of Dermatology, Institute of Cellular Medicine, Medical School, Newcastle University, Royal Victoria Infirmary and NIHR Newcastle Biomedical Research Centre Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
  • Woolf RT; Department of Dermatology & Photobiology, Ninewells Hospital and Medical School, Dundee, UK.
  • Hyseni AM; Pharmacy Department, Evelina London Children's Hospital, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Gerbens LAA; Institute of Pharmaceutical Science, King's College London, London, UK.
  • Spuls PI; Dermatology Centre, Salford Royal NHS Foundation Trust, NIHR Manchester Biomedical 17 Research Centre, University of Manchester, Manchester, UK.
  • Flohr C; St John's Institute of Dermatology, Guy's and St Thomas' NHS Foundation Trust, London, UK.
  • Middelkamp-Hup MA; Department of Dermatology, Amsterdam UMC, Location Academic Medical Center, University of Amsterdam, Amsterdam Public Health Research Institute, Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.
JAAD Int ; 10: 14-24, 2023 Mar.
Article in En | MEDLINE | ID: mdl-36387062

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JAAD Int Year: 2023 Document type: Article Affiliation country: Países Bajos

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JAAD Int Year: 2023 Document type: Article Affiliation country: Países Bajos